Ullmann Wealth Partners Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Ullmann Wealth Partners Group's LLY Position: Q3 2026 in Review
Ullmann Wealth Partners Group increased its Eli Lilly (LLY) stake by 3.3% in Q3 2026, buying an estimated $37.8K and bringing the position to 994 shares worth $1.15M. The position accounts for 0.1% of the portfolio, ranked #75.
Ullmann Wealth Partners Group first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.15M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Ullmann Wealth Partners Group held 994 shares of Eli Lilly worth $1.15M as of Q3 2026.
- Ullmann Wealth Partners Group bought 32 Eli Lilly shares in Q3 2026, an estimated $37.8K.
- Eli Lilly made up 0.1% of Ullmann Wealth Partners Group's portfolio in Q3 2026, its #75 holding.
- Ullmann Wealth Partners Group first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
- Ullmann Wealth Partners Group's Eli Lilly position peaked at $1.15M in Q2 2026.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Ullmann Wealth Partners Group's 13F filing for Q3 2026, filed 2 Nov 2026.